Avid Bioservices Inc expected to post a loss of 3 cents a share - Earnings Preview

Avid Bioservices

01/09/2023 12:01

* Avid Bioservices Inc  CDMO.OQ   CDMO.O  is expected
to show a
fall in quarterly revenue when it reports  results on September
4. 
    * The Tustin California-based  company is expected to report
 a
1.7% decrease in revenue to $36.086 million from $36.69 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Avid Bioservices
Inc is
for a loss of 3 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Avid
Bioservices
Inc is $20​, above​ its last closing price of $11.80. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Apr. 30 2023  0.00        0.00       0.00      Met     
 Jan. 31 2023  -0.04       -0.03      0.01      Beat    128.6
 Oct. 31 2022  0.00        0.00       -0.02     Missed  -300​
 Jul. 31 2022  0.04        0.04       0.02      Missed  -45.5
 ​​Apr.        0.01        0.01       0.01      Met     0
 30 2022                                                
 Jan. 31 2022  0.05        0.04       0.04      Met     0​
 Oct. 31 2021  0.03        0.03       0.06      Beat    140
 Jul. 31 2021  0.04        0.04       0.10      Beat    166.7
 This summary was machine generated September 1 at 11:01 GMT. 
All figures in US dollars  unless otherwise stated